Medicine
Cure8 research brief
Why This Matters
This paper maps where and how mitochondria-related IBD research has grown and what themes (like mitophagy, metabolism, and machine learning) are emerging — useful for researchers, funders, and clinicians tracking research directions.
Who Should Pay Attention
Researchers in mitochondrial biology and IBD, clinicians following research trends, funders, and science-policy stakeholders.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This paper is a bibliometric and network analysis mapping mitochondria-focused research in inflammatory bowel disease (IBD) from 2010–2025 using Web of Science records and tools like Bibliometrix, VOSviewer, and R.
The authors quantified publication growth, geographic and institutional contributions, collaboration networks, and thematic trends (for example: mitophagy, mitochondrial dynamics, metabolism, epithelial biology, and host–microbiome interactions).
The study found rising publication output over the period, concentrated contributions from China and the United States, recurring but uneven international collaboration, and a multidisciplinary, interconnected citation base. Recent thematic signals included mitophagy, mitochondrial dynamics, and use of machine learning within the literature.
This article does not present new clinical or biological experimental data; it summarizes publication patterns and themes in the existing literature. It explicitly warns that its mapping should not be interpreted as proof of biological causality or specific mechanistic conclusions.
Keep In Mind
Findings are derived from bibliometric analysis of publication records (Web of Science) and reflect publication patterns, not experimental evidence of biological mechanisms. The article’s depth here is based on the source abstract.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationMedicine
AuthorsHoushu Tu, Menglin Chen, Panpan Zhu +2 more
InstitutionSchool of Acupuncture-Moxibustion and Tuina, Jiangxi University of Chinese Medicine, Nanchang, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 9, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: The authors have no conflicts of interest to declare.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
A scoping review on emerging biomarkers in inflammatory bowel disease: Towards precision medicine in diagnosis and therapeutic management.
New, non-invasive biomarkers and AI-driven multi-omic approaches could make diagnosis and treatment of IBD more precise, helping patients avoid invasive tests and improving chances of choosing effective therapies sooner.
Emerging antimicrobial peptides in gastrointestinal disorders: Dual role in immunity and therapy.
AMPs are central to gut immune balance and are being explored as new therapies for IBD and related gut diseases. For people with Crohn’s or IBD, understanding AMPs helps explain research directions aimed at restoring...
Artificial Intelligence in the Nutritional Management of Inflammatory Bowel Disease: A Scoping Review.
AI could help identify dietary patterns, predict which patients might benefit from specific nutrition approaches, and provide personalized nutrition support — potentially improving inflammation and gut microbiome...